GH1 and acromegaly: Historically, due to several analytical limitations in GH and insulin-like growth factor I (IGF-I) assays, the confirmation of clinically suspected acromegaly was primarily based on dynamic tests involving the administration of substances known to acutely and physiologically modulate GH secretion.